TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer	Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast carcinoma, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma	Recruiting	Phase 1 / Phase 2	2024-11-12		NCT06532812

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Essen Biotech	17

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
District One Hospital	Beijing	China	17

Clinical trials